| Literature DB >> 29788947 |
Karen F Comer1,2,3, P Joseph Gibson4, Jian Zou5, Marc Rosenman6, Brian E Dixon7,8.
Abstract
BACKGROUND: Given the widespread adoption of electronic health record (EHR) systems in health care organizations, public health agencies are interested in accessing EHR data to improve health assessment and surveillance. Yet there exist few examples in the U.S. of governmental health agencies using EHR data routinely to examine disease prevalence and other measures of community health. The objective of this study was to explore local health department (LHD) professionals' perceptions of the usefulness of EHR-based community health measures, and to examine these perceptions in the context of LHDs' current access and use of sub-county data, data aggregated at geographic levels smaller than county.Entities:
Keywords: Community health assessment; Community health measure; Electronic health record; Health information exchange; Population health; Public health
Mesh:
Year: 2018 PMID: 29788947 PMCID: PMC5964696 DOI: 10.1186/s12889-018-5550-2
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Perceived Usefulness of Potential Community Health Measures
| Average Scores of Perceived Usefulnessa by LHD Sizeb | |||||
|---|---|---|---|---|---|
| Potential Community Health Measure | All | Small | Medium ( | Large | Very Large |
| 1. Vaccination Coverage School-age Children | 2.17 | 2.50 | 2.30 | 1.81 | 2.05 |
| 2. Flu Vaccination Coverage | 2.07 | 2.45 | 2.17 | 1.55 | 2.10 |
| 3. Prevalence Substance Abuse | 2.06 | 2.27 | 2.00 | 1.82 | 2.14 |
| 4. Hepatitis B and/or Hepatitis C | 2.05 | 2.32 | 2.26 | 1.82 | 1.76 |
| 5. Diabetes Prevalence | 2.03 | 2.23 | 2.13 | 1.81 | 1.95 |
| 6. HPV Vaccination Coverage | 1.99 | 2.18 | 2.17 | 1.48 | 2.09 |
| 7. Chlamydia/Gonorrhea/Syphilis Incidence | 1.92 | 2.10 | 1.96 | 1.64 | 2.00 |
| 8. Hypertension and Other Common Cardiovascular Disease Prevalence | 1.92 | 2.24 | 1.91 | 1.62 | 1.91 |
| 9. Asthma and COPD Prevalence | 1.91 | 2.18 | 1.78 | 1.50 | 2.18 |
| 10. Depression Prevalence | 1.85 | 1.90 | 1.55 | 1.87 | 2.09 |
| 11. HIV Screening | 1.83 | 1.95 | 1.86 | 1.52 | 1.95 |
| 12. Various Cancers Incidence | 1.82 | 2.14 | 1.64 | 1.68 | 1.82 |
| 13. Evidence of Violence or Trauma | 1.75 | 1.82 | 1.68 | 1.57 | 1.91 |
| 14. Chlamydia Screening | 1.69 | 1.76 | 1.78 | 1.48 | 1.73 |
| 15. Cholesterol Screening Patients with Cardiovascular Conditions | 1.69 | 2.00 | 1.83 |
| 1.48 |
| 16. Breast Cancer Screening | 1.67 | 2.05 | 1.55 | 1.45 | 1.64 |
| 17. Hemoglobin A1c (HbA1c) Testing, Diabetic Patients | 1.53 | 1.64 | 1.70 |
|
|
| 18. ER Use by Asthmatics | 1.49 | 1.55 | 1.24 | 1.18 | 2.00 |
| 19. Cholesterol Levels (LDL-C) < 100 mg/dL Cardiovascular Patients | 1.46 | 1.90 |
|
|
|
| 20. Hemoglobin A1c (HbA1c) Controlled < 8 Percent, Diabetic Patients |
| 1.57 |
|
|
|
| 21. Dental Caries Prevalence |
|
|
|
|
|
| 22. Asthma ADHD Prevalence Comorbidity Impact on ED Visits |
|
|
|
|
|
| 23. ER Use by People with Dental Pain or Infections |
|
|
|
|
|
aUsefulness (Avg Scores) Quartile 1 (Most useful): 2.00–2.50 Quartile 2: 1.77–1.99 Quartile 3: 1.45–1.76 Quartile 4 (Least useful): 0.86–1.44
bLHD Size Small: < 10 employees Medium: 11–50 employees Large: 51–250 employees Very Large: 251–1000 employees
Fig. 1Average scores of the usefulness of potential measures, by LHD size
Synthesis of Respondent Perceptions and Internal Assessment of Available Data in EHRs
| Potential Community Health Measure | Perceived Usefulnessa | Readily Available in EHRs | Selected for Pilot Implementation |
|---|---|---|---|
| 1. Vaccination Coverage School-age Childrenc | Most Useful | No | No |
| 2. Flu Vaccination Coveragec | No | No | |
| 3. Prevalence Substance Abusec | No | No | |
| 4. Hepatitis B and/or Hepatitis Cc | Yes | No | |
| 5. Diabetes Prevalence | Yes | Yes | |
| 6. HPV Vaccination Coveragec | Useful | No | No |
| 7. Chlamydia/Gonorrhea/Syphilis Incidence | Yes | Yes | |
| 8. Hypertension and Other Common Cardiovascular Disease Prevalence | Yes | Yes | |
| 9. Asthma and COPD Prevalence | Yes | Yes | |
| 10. Depression Prevalence | Yes | Yes | |
| 11. HIV Screeningc | Yes | No | |
| 12. Various Cancers Incidence | Yes | No | |
| 13. Evidence of Violence or Traumac | Somewhat Useful | No | No |
| 14. Chlamydia Screening | Yes | Yesd | |
| 15. Cholesterol Screening Patients with Cardiovascular Conditions | Yes | Yesd | |
| 16. Breast Cancer Screening | Yes | Yesd | |
| 17. Hemoglobin A1c (HbA1c) Testing, Diabetic Patients | Yes | Yesd | |
| 18. ER Use by Asthmatics | Yes | No | |
| 19. LDL-C Levels < 100 mg/dL for Patients with Cardiovascular Conditions | Yes | Yesd | |
| 20. Hemoglobin A1c (HbA1c) Controlled < 8 Percent, Diabetic Patients | Least Useful | Yes | Yesd |
| 21. Dental Caries Prevalencec | No | No | |
| 22. Asthma ADHD Prevalence Comorbidity Impact on ED Visitsc | No | No | |
| 23. ER Use by People with Dental Pain or Infectionsc | Yes | No | |
| 24. Colorectal Cancer Screening | Not measuredb | No | No |
aCategory derived from Quartiles in Table 2
bNot included in the survey
cThese measures were proposed by epidemiologists and department heads at MCPHD
dThese measures are commonly reported by health systems as part of the Healthcare Effectiveness Data and Information Set (HEDIS) to payers
Use of Sub-County Data
| Sub-County Data Use | Use by those with access | Desired use by those without access ( |
|---|---|---|
| % (n) | ||
| For community health needs assessment | 61% (20) | 64% (44) |
| For health improvement planning | 55% (18) | 64% (44 |
| To identify high-risk groups | 55% (18) | 73% (50) |
| To target interventions to appropriate populations | 52% (17) | 67% (46) |
| To identify disparities | 46% (15) | 52% (36) |
| For program evaluation | 36% (12) | 49% (34) |
| For improvement of routine public health functions | 36% (12) | 64% (44) |
| I do not use the available sub-county data. | 6% (2) | 7% (5) |
| Other | 9% (3) | |
Interest in Population Characteristics
| Population Characteristic | Highest priority | High priority | Of interest | Not applicable | No response |
|---|---|---|---|---|---|
| % (n) | % (n) | % (n) | % (n) | % (n) | |
| Age | 45.6 (41) | 34.4 (31) | 13.3 (12) | 2.2 (2) | 4.4 (4) |
| Socioeconomic Status | 36.7 (33) | 31.1 (28) | 17.8 (16) | 6.7 (6) | 7.8 (7) |
| Race/Ethnicity | 23.3 (21) | 25.6 (23) | 21.1 (19) | 15.6 (14) | 14.4 (13) |
| Gender | 17.8 (16) | 21.1 (19) | 30 (27) | 16.7 (15) | 14.4 (13) |
| Education | 14.4 (13) | 32.2 (29) | 27.8 (25) | 10.0 (9) | 15.6 (14) |
| Disabled | 7.8 (7) | 20.0 (18) | 37.8 (34) | 13.3 (12) | 21.1 (19) |
| Sexual Orientation | 6.7 (6) | 8.9 (8) | 32.2 (29) | 30.0 (27) | 22.2 (20) |
| Veterans | 1.1 (1) | 17.8 (16) | 34.4 (31) | 23.3 (21) | 23.3 (21) |
| Other | 1.1 (1) | 4.4 (4) | 0 (0) | 15.6 (14) | 78.9 (71) |